Marko Oblak

Title: Marko Oblak: Innovator in Pharmaceutical Formulations

Introduction

Marko Oblak is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations. With a total of 2 patents to his name, Oblak's work focuses on improving drug delivery and efficacy.

Latest Patents

Oblak's latest patents include a formulation containing afatinib and a stable quick dissolving dosage form comprising amoxicillin and clavulanic acid. The afatinib-containing formulation involves a process for preparing granules or particles that ensure optimal solubility and stability. This invention aims to enhance the therapeutic effectiveness of afatinib dimaleate for treating specific diseases. The second patent details a quick dissolving pharmaceutical formulation that combines amoxicillin and clavulanic acid, designed for rapid absorption and improved patient compliance.

Career Highlights

Throughout his career, Marko Oblak has worked with reputable companies, including Sandoz AG. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to innovate in drug formulation and delivery systems.

Collaborations

Oblak has collaborated with professionals such as Jan Pelipenko and Katja Kristan, contributing to the advancement of pharmaceutical technologies.

Conclusion

Marko Oblak's contributions to pharmaceutical formulations demonstrate his commitment to improving healthcare through innovation. His patents reflect a deep understanding of drug delivery systems and their impact on patient outcomes.